Friday, Sep 11, 2026 The claims desk. Receipts included. POWERED BY LENZ ↗
IsThis

Short-term trials of TA-65 showed no serious harms, but long-term cancer risk is unknown.

The Claim

Supplements that activate the telomerase enzyme are safe for human use.

Verified by Lenz ·

The Short Version

This claim significantly overstates the evidence. While a few small, short-term clinical trials (6–12 months) of specific supplements like TA-65 reported no serious adverse effects, the best available systematic review explicitly states that long-term cancer risk and chronic toxicity remain unaddressed, and a 12.4% treatment-emergent adverse-event rate was observed. Mechanistic and epidemiological evidence also links telomerase activation with cancer risk. Declaring these supplements broadly "safe for human use" is not supported by current science.

Caveats

  • The strongest evidence synthesis (a 2025 systematic review/meta-analysis) explicitly states that long-term carcinogenic potential and chronic toxicity of telomerase-activating supplements have not been established.
  • Short-term trials with small sample sizes cannot rule out rare or long-latency harms such as cancer; 'no observed safety concerns' in these studies does not equal proven safety.
  • The claim generalizes across all telomerase-activating supplements, but clinical data exists primarily for one product (TA-65/Astragalus-based), and formulations, doses, and purity vary widely across unregulated supplement markets.

The Receipts

  1. Effects of TA-65 on telomere length, functional outcomes, and inflammation: a systematic review and meta-analysis - PMC

    PMC

  2. A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study - PMC

    PMC

  3. A Natural Astragalus-Based Nutritional Supplement Lengthens Telomeres in a Middle-Aged Population: A Randomized, Double-Blind, Placebo-Controlled Study - PubMed

    PubMed

  4. Long telomeres and cancer risk: the price of cellular immortality - JCI

    JCI

  5. What's the latest update on the ongoing clinical trials related to Telomerase?

    Consensus

  6. FDA Approves MAIA Biotechnology's Telomerase Inhibitor Therapy - Patsnap Synapse

    Patsnap Synapse

  7. Telomerase Activating Supplements - Telomere Science Library

    Telomere Science Library

  8. Τelomerase inhibitors and activators in aging and cancer: A systematic review

    PubMed

  9. OBM Geriatrics | Telomerase and Cancer: A Complex Relationship - lidsen

    lidsen

  10. Telomerase Activity and the Risk of Lung Cancer - PMC

    PMC

+ 8 more sources — see the full list on Lenz

Filed Under

telomerase activating supplementstelomerase enzyme

More Fact Checks